Note: Ingredients listed on restricted chemical lists
EC/CAS
64742-95-6
Name of the chemical
Solvent naphtha (petroleum), light arom
Concentration
N/A
EC/CAS
25322-69-4
Name of the chemical
polypropyleneglycol
Concentration
N/A
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
N/A
EC/CAS
141-78-6
Name of the chemical
acetic acid, ethyl ester
Concentration
N/A
EC/CAS
123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
N/A
General Information
Revision date
2016-10-05
Product name
BlackTop
1.2.1 Relevant identified uses
Black Paint, Chassis Paint, Top Coat
Manufacturer Name
Advanced Protective Technologies, LLC
Icons in SDS
Company Information
company name
Advanced Protective Technologies, LLC
Section 2
SECTION 2: Hazards identification
OSHA Hazards NPFA
WHMIS Classification
Personal Protective (USA) (Canada) Transport Symbol Equipment Consumer Product Not Regulated under WHMIS Classifications for workplace Not Regulated B2 D1A D2A, D2B
Appearance/Odor
Black liquid with solvent odor Harmful by inhalation. Irritating to eyes, respiratory system and skin. inhalation and skin contact. Toxic gases/fumes may be given off during burning or thermal decomposition. Closed container may forcibly rupture under extreme heat or when contents have been contaminated with water. USA: While this material is a Consumer Commodity, this MSDS contains valuable information critical to the safe handling and proper use of the product. This MSDS should be retained and available for employees and other users of this product. This product is a hazardous material as defined by 29 CFR1910.1200, OSHA Hazard Communication Evaluation. Canada: As packaged this product is intended for consumer use, subject to the labeling requirements of the CCCR. While this product is not regulated under WHMIS, this MSDS contains valuable information critical to the safe handling and proper use of the product. This MSDS should be retained and available for employees and other users of this product.
Potential health effects
ACUTE (short term) see Section 8 for exposure controls
Principle Routes of Exposure
Inhalation, Ingestion, Skin contact, Eye contact Inhalation: Short-term inhalation can cause respiratory and mucous membrane irritation. Symptoms include eye and nose irritation, dry or sore throat, runny nose, shortness of breath, wheezing and laryngitis. Coughing with chest pain or tightness may also occur, frequently at night. Mists or vapors can probably cause headache, nausea, dizziness, reduced concentration, loss of coordination and other symptoms of central nervous system (CNS) depression. Overexposure to vapors, above the exposure limits listed in Section 8, may lead to bronchitis, bronchial spasm, and pulmonary edema (fluid in the lungs). Chemical or hypersensitivity pneumonitis, with flu-like symptoms of fever and chills, may also occur. These symptoms may occur during exposure or may be delayed several hours. Ingestion: Harmful if swallowed; may cause lung damage if swallowed. Ingestion may cause severe irritation to the mouth and digestive system. May cause vomiting. Small amounts of this product drawn into the lungs during ingestion or vomiting could cause a potentially life- threatening accumulation of fluid (pulmonary edema). Ingestion is not a typical route of occupational exposure. Skin: Irritating to the skin with symptoms of reddening, itching, and swelling. Persons previously sensitized can experience allergic skin reaction with symptoms of reddening, itching, swelling, and rash. Cured material is difficult to remove. Eye: Direct contact with the eyes may cause severe irritation including tearing, excess redness and swelling of the conjunctiva.
Long term hazards
see Section 11 for additional toxicological data Repeated or prolonged skin contact may cause dermatitis, with redness, blisters, cracking and swelling of the skin. Sensitization through inhalation or skin exposure: Individuals sensitized from prior contact to diisocyanates may experience asthma-like symptoms and/or allergic skin reactions. Respiratory symptoms may include coughing, difficult breathing and a feeling of tightness in the chest. Skin symptoms may include redness, scaling, rash, itching, hives and swelling of the arms and legs which can spread to the face and bodyEffects may be delayed. Occasionally, breathing difficulty may be life threatening. Decreased lung function has been associated with overexposure to diisocyanates. Long-term, high level exposure to organic solvents has been associated with a condition called "organic solvent syndrome". Symptoms such as excessive fatigue, reduced memory, pain and numbness in the legs, arms, hands and feet and behavioral changes have been observed in some people with long-term, high-level occupational exposure to organic solvents.
Medical Conditions Generally Aggravated by Exposure
Skin contact may aggravate an existing dermatitis. Asthma and other restrictive lung disorders, skin allergies and eczema may be aggravated by exposure to this product.
Interactions with other chemicals
Not Available
Environmental effects
Not available. Do not allow the product to be released into the environment